drugset / Trial / NCT05086393
Duloxetine RCT on Postop TKA Outcomes
RandomizedParallel-groupTriple-blindTreatment
Summary
The aim of this study is to determine if duloxetine is associated with differences in post-operative pain, patient-reported outcome measures, and opioid consumption in patients undergoing primary total knee arthroplasty compared to patients who do not receive the medication. If so, duloxetine has the potential to become widely incorporated into the multi-modal analgesic regimen given to patients following knee replacements.
Timeline
- Start
- 2021-11-01
- Primary completion
- 2025-06-01
- Completion
- 2025-07-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Duloxetine | Small molecule | 30 mg | Oral |